The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

Share Price Information for Dunedin Ent.it. (DNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 481.00
Bid: 472.00
Ask: 490.00
Change: -1.00 (-0.21%)
Spread: 18.00 (3.814%)
Open: 482.00
High: 0.00
Low: 0.00
Prev. Close: 482.00
DNE Live PriceLast checked at -
Dunedin Enterprise is an Investment Trust

To conduct an orderly realisation of its assets, to be effected in a manner that seeks to achieve a balance between maximising the value of the investments and progressively returning cash to Shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Preliminary NAV and Tender Offer Price

1 Nov 2022 07:00

RNS Number : 7780E
Dunedin Enterprise Inv Trust PLC
01 November 2022
 

Dunedin Enterprise Investment Trust PLC

 

LEI: 213800E2VLUZ5AF9Z434

 

Date: 1 November 2022

Time: 7.00am

 

Preliminary Unaudited Net Asset Value announcement for 30 September 2022

Announcement of Tender Price

 

The Board of Dunedin Enterprise Investment Trust PLC is pleased to announce a preliminary unaudited net asset value of 576.6p per share as at 30 September 2022 (567.5p as at 30 June 2022).

 

The preliminary unaudited net asset value has been calculated using the underlying managers' latest valuations (including those received since 30 September 2022), which remain subject to review by the Board of Directors. 

 

Based on those valuations, as at 30 September 2022, the Company's unlisted investments were valued at £43.9m. The Company also held cash balances of £29.9m and net current assets of £1.9m making a total net assets position of £75.7m. The finalised net asset value per share will be published around 16 November 2022.

 

Cash balances following the realisation of RED announced on 7 October 2022 amount to £54m.

 

The Company is due to pay an interim dividend of 34p per share on 24 November 2022. 

 

The Company sent shareholders a circular on 21 October 2022 (the "Circular") in relation to a proposed return of up to £41m to shareholders by way of a Tender Offer. In accordance with the terms of the Tender Offer, the Tender Price and the Basic Entitlement of shareholders under the Tender Offer has been calculated on the basis of the 30 September 2022 net asset value, ex-dividend, and are as follows:

 

· Tender Price - 537.1740p per share

· Basic Entitlement - 58.10 per cent.

 

The maximum number of shares that will be repurchased under the Tender Offer is 7,632,536 shares. The Tender Offer is conditional on the passing of the requisite resolution at the General Meeting to be held on 16 November 2022.

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended ("UK MAR"), and is being disclosed in accordance with the Company's obligations under Article 17 of UK MAR. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

Capitalised terms used in this announcement have the meanings given to them in the Circular.

 

For further information, please contact:

 

Dunedin LLP

Company Secretary

Email: info@dunedin.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENEALEFDFFAFFA
Date   Source Headline
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update
21st Jun 202110:28 amRNSDirector/PDMR Shareholding
12th May 20212:42 pmRNSResult of AGM
12th May 202111:31 amRNS1st Quarter Results
4th May 20217:00 amRNSPreliminary unaudited net asset value at 31/3/21
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:20 amRNSDirector/PDMR Shareholding
16th Mar 20218:19 amRNSDirector/PDMR Shareholding
16th Mar 20218:18 amRNSDirector/PDMR Shareholding
15th Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20217:00 amRNSPortfolio Update
1st Feb 20217:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/20
20th Nov 20207:47 amRNSDirector/PDMR Shareholding
20th Nov 20207:46 amRNSDirector/PDMR Shareholding
20th Nov 20207:44 amRNSDirector/PDMR Shareholding
20th Nov 20207:43 amRNSDirector/PDMR Shareholding
20th Nov 20207:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.